▶ 調査レポート

世界のワクチン産業2020-2026

• 英文タイトル:Global Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界のワクチン産業2020-2026 / Global Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3013412資料のイメージです。• レポートコード:D0MA3013412
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥539,000 (USD4,900)▷ お問い合わせ
  Multi User¥808,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,078,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、ワクチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ワクチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(組換えワクチン、ウイルスワクチン、多糖ワクチン、その他)、用途別市場規模(コレラ、B型肝炎、ジフテリア、破傷風、麻疹ワクチン、A型肝炎、生弱毒インフルエンザワクチン、ポリオワクチン、狂犬病ワクチン)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ワクチンの種類別市場2015-2026:組換えワクチン、ウイルスワクチン、多糖ワクチン、その他
・ワクチンの用途別市場2015-2026:コレラ、B型肝炎、ジフテリア、破傷風、麻疹ワクチン、A型肝炎、生弱毒インフルエンザワクチン、ポリオワクチン、狂犬病ワクチン
・ワクチンの北米市場分析
・ワクチンのアジア市場分析
・ワクチンの中南米市場分析
・ワクチンの中東・アフリカ市場分析
・関連企業情報:GSK、Sanofi、Merck、Pfizer、Novartis(GSK)、CSL、MedImmune LLC、J&J(Crucell)、China National Biotec、Tiantan、Hualan、Kangtai、Hissen、Jintan
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as foreign, destroy it, and “remember” it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Vaccines can be divided into recombinant vaccines, viral vaccines, polysaccharide vaccines and others. Recombinant vaccines and viral vaccines contain many kinds of vaccines, and the demand is larger than others kinds. But with the development of new technologies, more and more new types of vaccines will be popularized. The scope for disease prevention will be enlarged .The demand of other kinds is also increasing.
In 2019, the global Vaccines market size was US$ 39670 million and is forecast to US$ 58340 million in 2026, growing at a CAGR of 5.6% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Vaccines.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Vaccines market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Vaccines market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Vaccines market. Readers of the report can become informed about current and future trends of the global Vaccines market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Vaccines markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Vaccines market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Vaccines market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Vaccines market is segmented into
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others

Market Segment by Application, the Vaccines market is segmented into
Cholera
Hepatitis B
Diphtheria
Tetanus
Measles vaccine
Hepatitis A
Live attenuated influenza vaccine
Polio vaccine
Rabies vaccine

This report includes the following manufacturers; we can also add the other companies as you want.
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan

The study objectives are:
To analyze and research the global Vaccines status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Vaccines manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Vaccines are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Vaccines Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Vaccines Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Recombinant Vaccines
1.3.3 Viral Vaccines
1.3.4 Polysaccharide Vaccines
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Vaccines Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Cholera
1.4.3 Hepatitis B
1.4.4 Diphtheria
1.4.5 Tetanus
1.4.6 Measles vaccine
1.4.7 Hepatitis A
1.4.8 Live attenuated influenza vaccine
1.4.9 Polio vaccine
1.4.10 Rabies vaccine
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Vaccines Revenue (2015-2026)
2.1.1 Global Vaccines Revenue (2015-2026)
2.1.2 Global Vaccines Sales (2015-2026)
2.2 Vaccines Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Vaccines Sales by Regions (2015-2020)
2.2.2 Global Vaccines Revenue by Regions (2015-2020)
2.3 Global Top Vaccines Regions (Countries) Ranking by Market Size
2.4 Vaccines Industry Trends
2.4.1 Vaccines Market Top Trends
2.4.2 Market Drivers
2.4.3 Vaccines Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Vaccines Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Vaccines Manufacturers by Sales (2015-2020)
3.1.1 Global Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Vaccines Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Vaccines Sales in 2019
3.2 Global Top Manufacturers Vaccines by Revenue
3.2.1 Global Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines as of 2019)
3.4 Global Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Vaccines Market
3.7 Key Manufacturers Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Vaccines Historic Market Review by Type (2015-2020)
4.1.2 Global Vaccines Sales Market Share by Type (2015-2020)
4.1.3 Global Vaccines Revenue Market Share by Type (2015-2020)
4.1.4 Vaccines Price by Type (2015-2020)
4.1 Global Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Vaccines Sales Forecast by Type (2021-2026)
4.2.3 Global Vaccines Revenue Forecast by Type (2021-2026)
4.2.4 Vaccines Price Forecast by Type (2021-2026)

5 Global Vaccines Market Size by Application
5.1 Global Vaccines Historic Market Review by Application (2015-2020)
5.1.2 Global Vaccines Sales Market Share by Application (2015-2020)
5.1.3 Global Vaccines Revenue Market Share by Application (2015-2020)
5.1.4 Vaccines Price by Application (2015-2020)
5.2 Global Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Vaccines Sales Forecast by Application (2021-2026)
5.2.3 Global Vaccines Revenue Forecast by Application (2021-2026)
5.2.4 Vaccines Price Forecast by Application (2021-2026)

6 North America
6.1 North America Vaccines Breakdown Data by Company
6.2 North America Vaccines Breakdown Data by Type
6.3 North America Vaccines Breakdown Data by Application
6.4 North America Vaccines Breakdown Data by Countries
6.4.1 North America Vaccines Sales by Countries
6.4.2 North America Vaccines Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Vaccines Breakdown Data by Company
7.2 Europe Vaccines Breakdown Data by Type
7.3 Europe Vaccines Breakdown Data by Application
7.4 Europe Vaccines Breakdown Data by Countries
7.4.1 Europe Vaccines Sales by Countries
7.4.2 Europe Vaccines Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Vaccines Breakdown Data by Company
8.2 Asia Pacific Vaccines Breakdown Data by Type
8.3 Asia Pacific Vaccines Breakdown Data by Application
8.4 Asia Pacific Vaccines Breakdown Data by Regions
8.4.1 Asia Pacific Vaccines Sales by Regions
8.4.2 Asia Pacific Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Vaccines Breakdown Data by Company
9.2 Latin America Vaccines Breakdown Data by Type
9.3 Latin America Vaccines Breakdown Data by Application
9.4 Latin America Vaccines Breakdown Data by Countries
9.4.1 Latin America Vaccines Sales by Countries
9.4.2 Latin America Vaccines Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Vaccines Breakdown Data by Type
10.2 Middle East and Africa Vaccines Breakdown Data by Application
10.3 Middle East and Africa Vaccines Breakdown Data by Countries
10.3.1 Middle East and Africa Vaccines Sales by Countries
10.3.2 Middle East and Africa Vaccines Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Business Overview and Total Revenue (2019 VS 2018)
11.1.3 GSK Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 GSK Vaccines Products and Services
11.1.5 GSK SWOT Analysis
11.1.6 GSK Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Sanofi Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Sanofi Vaccines Products and Services
11.2.5 Sanofi SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Merck Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Merck Vaccines Products and Services
11.3.5 Merck SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Pfizer Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Pfizer Vaccines Products and Services
11.4.5 Pfizer SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Novartis(GSK)
11.5.1 Novartis(GSK) Corporation Information
11.5.2 Novartis(GSK) Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Novartis(GSK) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Novartis(GSK) Vaccines Products and Services
11.5.5 Novartis(GSK) SWOT Analysis
11.5.6 Novartis(GSK) Recent Developments
11.6 CSL
11.6.1 CSL Corporation Information
11.6.2 CSL Business Overview and Total Revenue (2019 VS 2018)
11.6.3 CSL Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 CSL Vaccines Products and Services
11.6.5 CSL SWOT Analysis
11.6.6 CSL Recent Developments
11.7 MedImmune LLC
11.7.1 MedImmune LLC Corporation Information
11.7.2 MedImmune LLC Business Overview and Total Revenue (2019 VS 2018)
11.7.3 MedImmune LLC Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 MedImmune LLC Vaccines Products and Services
11.7.5 MedImmune LLC SWOT Analysis
11.7.6 MedImmune LLC Recent Developments
11.8 J&J(Crucell)
11.8.1 J&J(Crucell) Corporation Information
11.8.2 J&J(Crucell) Business Overview and Total Revenue (2019 VS 2018)
11.8.3 J&J(Crucell) Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 J&J(Crucell) Vaccines Products and Services
11.8.5 J&J(Crucell) SWOT Analysis
11.8.6 J&J(Crucell) Recent Developments
11.9 China National Biotec
11.9.1 China National Biotec Corporation Information
11.9.2 China National Biotec Business Overview and Total Revenue (2019 VS 2018)
11.9.3 China National Biotec Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 China National Biotec Vaccines Products and Services
11.9.5 China National Biotec SWOT Analysis
11.9.6 China National Biotec Recent Developments
11.10 Tiantan
11.10.1 Tiantan Corporation Information
11.10.2 Tiantan Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Tiantan Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Tiantan Vaccines Products and Services
11.10.5 Tiantan SWOT Analysis
11.10.6 Tiantan Recent Developments
11.11 Hualan
11.11.1 Hualan Corporation Information
11.11.2 Hualan Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Hualan Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Hualan Vaccines Products and Services
11.11.5 Hualan SWOT Analysis
11.11.6 Hualan Recent Developments
11.12 Kangtai
11.12.1 Kangtai Corporation Information
11.12.2 Kangtai Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Kangtai Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Kangtai Vaccines Products and Services
11.12.5 Kangtai SWOT Analysis
11.12.6 Kangtai Recent Developments
11.13 Hissen
11.13.1 Hissen Corporation Information
11.13.2 Hissen Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Hissen Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Hissen Vaccines Products and Services
11.13.5 Hissen SWOT Analysis
11.13.6 Hissen Recent Developments
11.14 Jintan
11.14.1 Jintan Corporation Information
11.14.2 Jintan Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Jintan Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Jintan Vaccines Products and Services
11.14.5 Jintan SWOT Analysis
11.14.6 Jintan Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Vaccines Sales Channels
12.2.2 Vaccines Distributors
12.3 Vaccines Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Vaccines Sales Forecast (2021-2026)
13.1.1 Global Vaccines Sales Forecast by Regions (2021-2026)
13.1.2 Global Vaccines Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Vaccines Sales Forecast (2021-2026)
13.2.2 North America Vaccines Revenue Forecast (2021-2026)
13.2.3 North America Vaccines Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Vaccines Sales Forecast (2021-2026)
13.3.2 Europe Vaccines Revenue Forecast (2021-2026)
13.3.3 Europe Vaccines Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Vaccines Sales Forecast (2021-2026)
13.4.2 Asia Pacific Vaccines Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Vaccines Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Vaccines Sales Forecast (2021-2026)
13.5.2 Latin America Vaccines Revenue Forecast (2021-2026)
13.5.3 Latin America Vaccines Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Vaccines Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Vaccines Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Vaccines Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Vaccines Key Market Segments
Table 2. Ranking of Global Top Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vaccines Market Size Growth Rate by Type 2021-2026 (K Pcs) & (Million US$)
Table 4. Major Manufacturers of Recombinant Vaccines
Table 5. Major Manufacturers of Viral Vaccines
Table 6. Major Manufacturers of Polysaccharide Vaccines
Table 7. Major Manufacturers of Others
Table 8. Global Vaccines Market Share by Application 2019-2025 (K Pcs)
Table 9. Global Vaccines Market Size by Regions 2015-2020 (K Pcs) & (Million US$)
Table 10. Global Vaccines Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Vaccines Sales Market Share by Regions 2015-2020
Table 12. Global Vaccines Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Vaccines Revenue Market Share by Regions 2015-2020
Table 14. Top Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Vaccines Key Drivers: Impact Analysis (2021-2026)
Table 17. Vaccines Key Challenges
Table 18. Main Points Interviewed from Key Vaccines Players: Views for Future
Table 19. Global Vaccines Sales by Manufacturers (2015-2020) (K Pcs)
Table 20. Global Vaccines Sales Share by Manufacturers (2015-2020)
Table 21. Vaccines Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Vaccines Revenue Share by Manufacturers (2015-2020)
Table 23. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines as of 2019)
Table 25. Key Manufacturers Vaccines Average Selling Price (ASP) (2015-2020) (USD/Pcs)
Table 26. Key Manufacturers Vaccines Plants/Factories Distribution
Table 27. Key Manufacturers Vaccines Area Served
Table 28. Date of Key Manufacturers Enter into Vaccines Market
Table 29. Key Manufacturers Vaccines Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Recombinant Vaccines Sales and Revenue (2015-2020) (K Pcs) & (Million US$)
Table 32. Global Viral Vaccines Sales and Revenue (2015-2020) (K Pcs) & (Million US$)
Table 33. Global Polysaccharide Vaccines Sales ana Revenue (2015-2020) (K Pcs) & (Million US$)
Table 34. Global Others Sales ana Revenue (2015-2020) (K Pcs) & (Million US$)
Table 35. Global Vaccines Sales (K Pcs) by Type (2015-2020)
Table 36. Global Vaccines Sales Share by Type (2015-2020)
Table 37. Global Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Vaccines Price (K Pcs) by Type (2015-2020)
Table 39. Global Vaccines Sales (K Pcs) by Type (2021-2026)
Table 40. Global Vaccines Sales Share by Type (2021-2026)
Table 41. Global Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Vaccines Revenue Share by Type (2021-2026)
Table 43. Global Vaccines Price (K Pcs) by Type (2021-2026)
Table 44. Global Vaccines Sales (K Pcs) by Application (2015-2020)
Table 45. Global Vaccines Sales Share by Application (2015-2020)
Table 46. Global Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Vaccines Price by Application 2015-2020 (USD/Pcs)
Table 48. Global Vaccines Sales by Application (2015-2020) (K Pcs)
Table 49. Global Vaccines Sales Share by Application (2015-2020)
Table 50. Global Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Vaccines Revenue Share by Application (2021-2026)
Table 52. Global Vaccines Price (K Pcs) by Application (2021-2026)
Table 53. North America Vaccines Sales by Company (2015-2020) (K Pcs)
Table 54. North America Vaccines Sales Market Share by Company (2015-2020)
Table 55. North America Vaccines Sales by Type (2015-2020) (K Pcs)
Table 56. North America Vaccines Sales Market Share by Type (2015-2020)
Table 57. North America Vaccines Sales by Application (2015-2020) (K Pcs)
Table 58. North America Vaccines Sales Market Share by Application (2015-2020)
Table 59. North America Vaccines Sales by Countries (2015-2020) (K Pcs)
Table 60. North America Vaccines Sales Market Share by Countries (2015-2020)
Table 61. North America Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Vaccines Revenue Market Share by Countries (2015-2020)
Table 63. Europe Vaccines Sales by Company (2015-2020) (K Pcs)
Table 64. Europe Vaccines Sales Market Share by Company (2015-2020)
Table 65. Europe Vaccines Sales by Type (2015-2020) (K Pcs)
Table 66. Europe Vaccines Sales Market Share by Type (2015-2020)
Table 67. Europe Vaccines Sales by Application (2015-2020) (K Pcs)
Table 68. Europe Vaccines Sales Market Share by Application (2015-2020)
Table 69. Europe Vaccines Sales by Countries (2015-2020) (K Pcs)
Table 70. Europe Vaccines Sales Market Share by Countries (2015-2020)
Table 71. Europe Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Vaccines Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Vaccines Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia Pacific Vaccines Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Vaccines Sales by Type (2015-2020) (K Pcs)
Table 76. Asia Pacific Vaccines Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Vaccines Sales by Application (2015-2020) (K Pcs)
Table 78. Asia Pacific Vaccines Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Vaccines Sales by Countries (2015-2020) (K Pcs)
Table 80. Asia Pacific Vaccines Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Vaccines Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Vaccines Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Vaccines Sales by Company (2015-2020) (K Pcs)
Table 84. Latin America Vaccines Sales Market Share by Company (2015-2020)
Table 85. Latin America Vaccines Sales by Type (2015-2020) (K Pcs)
Table 86. Latin America Vaccines Sales Market Share by Type (2015-2020)
Table 87. Latin America Vaccines Sales by Application (2015-2020) (K Pcs)
Table 88. Latin America Vaccines Sales Market Share by Application (2015-2020)
Table 89. Latin America Vaccines Sales by Countries (2015-2020) (K Pcs)
Table 90. Latin America Vaccines Sales Market Share by Countries (2015-2020)
Table 91. Latin America Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Vaccines Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Vaccines Sales by Type (2015-2020) (K Pcs)
Table 94. Middle East and Africa Vaccines Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Vaccines Sales by Application (2015-2020) (K Pcs)
Table 96. Middle East and Africa Vaccines Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Vaccines Sales by Countries (2015-2020) (K Pcs)
Table 98. Middle East and Africa Vaccines Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Vaccines Revenue Market Share by Countries (2015-2020)
Table 101. GSK Company Details
Table 102. GSK Description and Business Overview
Table 103. GSK Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. GSK Vaccines Sales Growth Rate (2015-2020)
Table 105. GSK Vaccines Sales Market Share in Global Market
Table 106. GSK Recent Development
Table 107. Sanofi Company Details
Table 108. Sanofi Description and Business Overview
Table 109. Sanofi Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Sanofi Vaccines Sales Growth Rate (2015-2020)
Table 111. Sanofi Vaccines Sales Market Share in Global Market
Table 112. Sanofi Recent Development
Table 113. Merck Company Details
Table 114. Merck Description and Business Overview
Table 115. Merck Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Merck Vaccines Sales Growth Rate (2015-2020)
Table 117. Merck Vaccines Sales Market Share in Global Market
Table 118. Merck Recent Development
Table 119. Pfizer Company Details
Table 120. Pfizer Description and Business Overview
Table 121. Pfizer Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Pfizer Vaccines Sales Growth Rate (2015-2020)
Table 123. Pfizer Vaccines Sales Market Share in Global Market
Table 124. Pfizer Recent Development
Table 125. Novartis(GSK) Company Details
Table 126. Novartis(GSK) Description and Business Overview
Table 127. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Novartis(GSK) Vaccines Sales Growth Rate (2015-2020)
Table 129. Novartis(GSK) Vaccines Sales Market Share in Global Market
Table 130. Novartis(GSK) Recent Development
Table 131. CSL Company Details
Table 132. CSL Description and Business Overview
Table 133. CSL Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 134. CSL Vaccines Sales Growth Rate (2015-2020)
Table 135. CSL Vaccines Sales Market Share in Global Market
Table 136. CSL Recent Development
Table 137. MedImmune LLC Company Details
Table 138. MedImmune LLC Description and Business Overview
Table 139. MedImmune LLC Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. MedImmune LLC Vaccines Sales Growth Rate (2015-2020)
Table 141. MedImmune LLC Vaccines Sales Market Share in Global Market
Table 142. MedImmune LLC Recent Development
Table 143. J&J(Crucell) Company Details
Table 144. J&J(Crucell) Description and Business Overview
Table 145. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. J&J(Crucell) Vaccines Sales Growth Rate (2015-2020)
Table 147. J&J(Crucell) Vaccines Sales Market Share in Global Market
Table 148. J&J(Crucell) Recent Development
Table 149. China National Biotec Company Details
Table 150. China National Biotec Description and Business Overview
Table 151. China National Biotec Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 152. China National Biotec Vaccines Sales Growth Rate (2015-2020)
Table 153. China National Biotec Vaccines Sales Market Share in Global Market
Table 154. China National Biotec Recent Development
Table 155. Tiantan Company Details
Table 156. Tiantan Description and Business Overview
Table 157. Tiantan Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Tiantan Vaccines Sales Growth Rate (2015-2020)
Table 159. Tiantan Vaccines Sales Market Share in Global Market
Table 160. Tiantan Recent Development
Table 161. Hualan Company Details
Table 162. Hualan Description and Business Overview
Table 163. Hualan Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 164. Hualan Vaccines Sales Growth Rate (2015-2020)
Table 165. Hualan Vaccines Sales Market Share in Global Market
Table 166. Hualan Recent Development
Table 167. Kangtai Company Details
Table 168. Kangtai Description and Business Overview
Table 169. Kangtai Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 170. Kangtai Vaccines Sales Growth Rate (2015-2020)
Table 171. Kangtai Vaccines Sales Market Share in Global Market
Table 172. Kangtai Recent Development
Table 173. Hissen Company Details
Table 174. Hissen Description and Business Overview
Table 175. Hissen Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 176. Hissen Vaccines Sales Growth Rate (2015-2020)
Table 177. Hissen Vaccines Sales Market Share in Global Market
Table 178. Hissen Recent Development
Table 179. Jintan Company Details
Table 180. Jintan Description and Business Overview
Table 181. Jintan Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 182. Jintan Vaccines Sales Growth Rate (2015-2020)
Table 183. Jintan Vaccines Sales Market Share in Global Market
Table 184. Jintan Recent Development
Table 185. Vaccines Distributors List
Table 186. Vaccines Customers List
Table 187. Global Vaccines Sales Forecast 2021-2026 (K Pcs) & (Million US$)
Table 188. Global Vaccines Sales Forecast by Type 2021-2026 (K Pcs)
Table 189. Global Vaccines Sales Forecast by Application 2021-2026 (K Pcs)
Table 190. Global Vaccines Sales Forecast by Regions 2021-2026 (K Pcs)
Table 191. Global Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 192. North America Vaccines Sales Forecast by Countries 2021-2026 (K Pcs)
Table 193. North America Vaccines Revenue Forecast by Countries 2021-2026
Table 194. Europe Vaccines Sales Forecast by Countries 2021-2026 (K Pcs)
Table 195. Europe Vaccines Revenue Market Share Forecast by Countries 2021-2026
Table 196. Asia Pacific Vaccines Sales Forecast by Regions 2021-2026 (K Pcs)
Table 197. Asia Pacific Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 198. Latin America Vaccines Sales Forecast by Countries 2021-2026 (K Pcs)
Table 199. Latin America Vaccines Revenue Forecast by Countries 2021-2026 (Million US$)
Table 200. Middle East and Africa Vaccines Sales Forecast by Regions 2021-2026 (K Pcs)
Table 201. Middle East and Africa Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines Product Picture
Figure 2. Global Vaccines Sales Market Shar by Type 2015-2026
Figure 3. Recombinant Vaccines Figures
Figure 4. Viral Vaccines Figures
Figure 5. Polysaccharide Vaccines Figures
Figure 6. Others Figures
Figure 7. Global Vaccines Sales Market Share by Application in 2019 & 2026
Figure 8. Cholera Use Case
Figure 9. Hepatitis B Use Case
Figure 10. Diphtheria Use Case
Figure 11. Tetanus Use Case
Figure 12. Measles vaccine Use Case
Figure 13. Hepatitis A Use Case
Figure 14. Live attenuated influenza vaccine Use Case
Figure 15. Polio vaccine Use Case
Figure 16. Rabies vaccine Use Case
Figure 17. Vaccines Report Years Considered
Figure 18. Global Vaccines Market Size 2015-2026 (Million US$)
Figure 19. Global Vaccines Sales 2015-2020 (K Pcs)
Figure 20. Global Vaccines Market Size Market Share by Regions 2015-2020
Figure 21. Global Vaccines Sales Market Share by Regions in 2019
Figure 22. Porter's Five Forces Analysis
Figure 23. Global Vaccines Sales Share by Manufacturers in 2019
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccines Sales in 2019
Figure 25. Vaccines Value Share by Manufacturers in 2019
Figure 26. Vaccines Revenue Share by Manufacturers In 2019
Figure 27. Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Vaccines Revenue Share by Type (2015-2020)
Figure 29. Global Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Vaccines Market Share by Price Range (2015-2020)
Figure 31. Global Vaccines Revenue Share by Application (2015-2020)
Figure 32. Global Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 33. North America Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. U.S. Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. Canada Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Europe Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. Germany Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. France Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.K. Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Italy Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Russia Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Asia Pacific Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 43. China Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Japan Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. South Korea Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. India Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Australia Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Taiwan Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Indonesia Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Thailand Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Malaysia Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Philippines Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Vietnam Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Latin America Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 55. Mexico Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Brazil Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Argentina Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Middle East and Africa Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 59. Turkey Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Saudi Arabia Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. U.A.E Vaccines Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Novartis(GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. MedImmune LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. J&J(Crucell) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. China National Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Tiantan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Hualan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Kangtai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Hissen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 75. Jintan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Vaccines Value Chain
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. North America Vaccines Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 80. North America Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 81. Europe Vaccines Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 82. Europe Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 83. Asia Pacific Vaccines Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 84. Asia Pacific Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 85. Latin America Vaccines Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 86. Latin America Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 87. Middle East and Africa Vaccines Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 88. Middle East and Africa Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed